Literature DB >> 26292982

Further evidence for sustained systemic inflammation in xenograft recipients (SIXR).

Hayato Iwase1, Burcin Ekser1,2, Huidong Zhou1,3, Hong Liu4, Vikas Satyananda1, Rishab Humar1, Pooja Humar1, Hidetaka Hara1, Cassandra Long1, Jay K Bhama5, Pietro Bajona1, Yi Wang3, Martin Wijkstrom1, David Ayares6, Mohamed B Ezzelarab1, David K C Cooper1.   

Abstract

INTRODUCTION: In pig-to-baboon heart/artery patch transplantation models, adequate costimulation blockade prevents a T-cell response. After heart transplantation, coagulation dysfunction (thrombocytopenia, reduced fibrinogen, increased D-dimer) and inflammation (increased C-reactive protein [CRP]) develop. We evaluated whether coagulation dysfunction and/or inflammation can be detected following pig artery patch transplantation.
METHODS: Baboons received heart (n = 8) or artery patch (n = 16) transplants from genetically engineered pigs and a costimulation blockade-based regimen. Heart grafts functioned for 15-130 days. Artery recipients were euthanized after 28-84 days. Platelet counts, fibrinogen, D-dimer, and CRP were measured.
RESULTS: Thrombocytopenia and reduced fibrinogen developed only in recipients of hearts not expressing a coagulation-regulatory protein (n = 4), but not in other heart or patch recipients. However, in heart recipients (n = 8), there were sustained increases in D-dimer (<0.5 to 1.9 ug/ml [P < 0.01]) and CRP (0.26-2.2 mg/dl [P < 0.01]). In recipients of artery patches, there were also sustained increases in D-dimer (<0.5 to 1.4 ug/ml [P < 0.01]) and CRP (0.26 to 1.5 mg/dl [P < 0.001]). An IL-6R antagonist suppressed the increase in CRP, but not D-dimer.
CONCLUSION: The pig artery patch model has proved valuable for determining immunosuppressive regimens that prevent sensitization to pig antigens. This model also provides information on the sustained systemic inflammation in xenograft recipients (SIXR). An IL-6R antagonist may help suppress this response.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-reactive protein; D-dimer; IL-6R blockade; baboons; coagulation; genetically engineered; inflammation; pigs; platelets; xenotransplantation

Mesh:

Year:  2015        PMID: 26292982      PMCID: PMC4575631          DOI: 10.1111/xen.12182

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  40 in total

1.  C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

Authors:  G D Lowe; J W Yarnell; A Rumley; D Bainton; P M Sweetnam
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-04       Impact factor: 8.311

Review 2.  Inflammation and thrombosis.

Authors:  C T Esmon
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

3.  C-reactive protein in the diagnosis of deep vein thrombosis.

Authors:  Robert A Bucek; Markus Reiter; Peter Quehenberger; Erich Minar
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

4.  Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway.

Authors:  D G Ritchie; B A Levy; M A Adams; G M Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons.

Authors:  P J Cowan; A Aminian; H Barlow; A A Brown; C G Chen; N Fisicaro; D M Francis; D J Goodman; W Han; M Kurek; M B Nottle; M J Pearse; E Salvaris; T A Shinkel; G V Stainsby; A B Stewart; A J d'Apice
Journal:  Transplantation       Date:  2000-06-27       Impact factor: 4.939

6.  C-reactive protein levels and outcomes after statin therapy.

Authors:  Paul M Ridker; Christopher P Cannon; David Morrow; Nader Rifai; Lynda M Rose; Carolyn H McCabe; Marc A Pfeffer; Eugene Braunwald
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

7.  Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates.

Authors:  L Bühler; M Basker; I P Alwayn; C Goepfert; H Kitamura; T Kawai; S Gojo; T Kozlowski; F L Ierino; M Awwad; D H Sachs; R Sackstein; S C Robson; D K Cooper
Journal:  Transplantation       Date:  2000-11-15       Impact factor: 4.939

8.  Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.

Authors:  Bruce E Loveland; Julie Milland; Peter Kyriakou; Bruce R Thorley; Dale Christiansen; Marc B Lanteri; Mark Regensburg; Maureen Duffield; Andrew J French; Lindsay Williams; Louise Baker; Malcolm R Brandon; Pei-Xiang Xing; Del Kahn; Ian F C McKenzie
Journal:  Xenotransplantation       Date:  2004-03       Impact factor: 3.907

9.  Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons.

Authors:  Stuart L Houser; Kenji Kuwaki; Christoph Knosalla; Frank J M F Dor; Bernd Gollackner; Jane Cheng; Akira Shimizu; Henk-Jan Schuurman; David K C Cooper
Journal:  Xenotransplantation       Date:  2004-09       Impact factor: 3.907

10.  A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides.

Authors:  T S Edgington; L K Curtiss; E F Plow
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

View more
  18 in total

1.  An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.

Authors:  Tao Li; Whayoung Lee; Hidetaka Hara; Cassandra Long; Mohamed Ezzelarab; David Ayares; Hai Huang; Yi Wang; Charles T Esmon; David K C Cooper; Hayato Iwase
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

2.  B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Authors:  Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase
Journal:  Transpl Immunol       Date:  2018-08-06       Impact factor: 1.708

3.  Therapeutic regulation of systemic inflammation in xenograft recipients.

Authors:  Hayato Iwase; Hong Liu; Tao Li; Zhongquiang Zhang; Bingsi Gao; Hidetaka Hara; Martin Wijkstrom; Cassandra Long; Ryan Saari; David Ayares; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2017-03-12       Impact factor: 3.907

4.  Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts.

Authors:  Hayato Iwase; Hidetaka Hara; Mohamed Ezzelarab; Tao Li; Zhongqiang Zhang; Bingsi Gao; Hong Liu; Cassandra Long; Yi Wang; Amy Cassano; Edwin Klein; Carol Phelps; David Ayares; Abhinav Humar; Martin Wijkstrom; David K C Cooper
Journal:  Xenotransplantation       Date:  2017-03-17       Impact factor: 3.907

5.  Delayed revascularization of islets after transplantation by IL-6 blockade in pig to non-human primate islet xenotransplantation model.

Authors:  Byoung-Hoon Min; Jun-Seop Shin; Jong-Min Kim; Seong-Jun Kang; Hyun-Je Kim; Il-Hee Yoon; Su-Kyoung Park; Ji-Won Choi; Min-Suk Lee; Chung-Gyu Park
Journal:  Xenotransplantation       Date:  2017-12-06       Impact factor: 3.907

Review 6.  Low anti-pig antibody levels are key to the success of solid organ xenotransplantation: But is this sufficient?

Authors:  David K C Cooper; Mohamed B Ezzelarab; Hidetaka Hara
Journal:  Xenotransplantation       Date:  2017-10-25       Impact factor: 3.907

7.  Thyroid hormone: relevance to xenotransplantation.

Authors:  Hayato Iwase; Burcin Ekser; Hidetaka Hara; Mohamed B Ezzelarab; Cassandra Long; Angus W Thomson; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2016-07-04       Impact factor: 3.907

Review 8.  Perspectives on the Optimal Genetically Engineered Pig in 2018 for Initial Clinical Trials of Kidney or Heart Xenotransplantation.

Authors:  David K C Cooper; Mohamed Ezzelarab; Hayato Iwase; Hidetaka Hara
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

Review 9.  Cardiac xenotransplantation: a promising way to treat advanced heart failure.

Authors:  Songren Shu; Jie Ren; Jiangping Song
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

10.  Stable expression of the human thrombomodulin transgene in pig endothelial cells is associated with a reduction in the inflammatory response.

Authors:  Hidetaka Hara; Hayato Iwase; Huy Nguyen; Yuko Miyagawa; Kasinath Kuravi; Jeremy B Foote; Will Eyestone; Carol Phelps; David Ayares; David K C Cooper
Journal:  Cytokine       Date:  2021-06-04       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.